{
    "organizations": [],
    "uuid": "237a4dbda95b2a847a5765f136f0b7d7359704a7",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-hemostemix-announces-us-fda-clinic/brief-hemostemix-announces-u-s-fda-clinical-trial-approval-idUSASC09WHK",
    "ord_in_thread": 0,
    "title": "BRIEF-Hemostemix Announces U.S. FDA Clinical Trial Approval",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 19 (Reuters) - Hemostemix Inc:\n* HEMOSTEMIX ANNOUNCES US FDA CLINICAL TRIAL APPROVAL * HEMOSTEMIX INC - UNITED STATES FOOD AND DRUG ADMINISTRATION HAS RAISED NO OBJECTIONS TO COMPANYâ€™S INVESTIGATIONAL NEW DRUG APPLICATION Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-19T20:42:00.000+03:00",
    "crawled": "2018-04-20T11:41:32.002+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "hemostemix",
        "inc",
        "hemostemix",
        "announces",
        "u",
        "fda",
        "clinical",
        "trial",
        "approval",
        "hemostemix",
        "inc",
        "united",
        "state",
        "food",
        "drug",
        "administration",
        "raised",
        "objection",
        "company",
        "investigational",
        "new",
        "drug",
        "application",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}